These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6315039)
1. Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris. Silke B; Verma SP; Hussain M; Nelson GI; Okoli RC; Taylor SH Br J Clin Pharmacol; 1983 Nov; 16(5):529-35. PubMed ID: 6315039 [TBL] [Abstract][Full Text] [Related]
2. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris. Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345 [TBL] [Abstract][Full Text] [Related]
3. Haemodynamic dose-response effects of i.v. verapamil in coronary artery disease. Silke B; Verma SP; Ahuja RC; Nelson GI; Hussain M; Taylor SH Herz; 1984 Dec; 9(6):353-61. PubMed ID: 6510876 [TBL] [Abstract][Full Text] [Related]
4. Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease. Silke B; Verma SP; Nelson GI; Hussain M; Taylor SH Br J Clin Pharmacol; 1984 Nov; 18(5):717-24. PubMed ID: 6508981 [TBL] [Abstract][Full Text] [Related]
5. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris. Majid PA; Schreuder JE; de Feyter PJ; Roos JP J Cardiovasc Pharmacol; 1980; 2(4):435-44. PubMed ID: 6156341 [TBL] [Abstract][Full Text] [Related]
6. Dose-response effects of cardioselective beta blockade in coronary artery disease. Silke B; Nelson G; Hussain M; Verma SP; Taylor SH Clin Pharmacol Ther; 1984 Jul; 36(1):40-6. PubMed ID: 6734047 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina. Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH Clin Pharmacol Ther; 1986 Jan; 39(1):5-14. PubMed ID: 2935349 [TBL] [Abstract][Full Text] [Related]
8. Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease. Silke B; Nelson GI; Ahuja RC; Okoli RC; Taylor SH Eur J Clin Pharmacol; 1983; 25(2):157-65. PubMed ID: 6628498 [TBL] [Abstract][Full Text] [Related]
9. Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1981 Jul; 22(1):1-25. PubMed ID: 7261952 [TBL] [Abstract][Full Text] [Related]
10. Haemodynamic dose-response effects of UK-52,046 in ischaemic disease with or without impaired left ventricular function. Silke B; Zezulka AV; Verma SP; Tham TC; Taylor SH Br J Clin Pharmacol; 1990 Jun; 29(6):749-58. PubMed ID: 1974144 [TBL] [Abstract][Full Text] [Related]
11. Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man. Wellstein A; Palm D Eur J Clin Pharmacol; 1985; 29(3):293-300. PubMed ID: 3000796 [TBL] [Abstract][Full Text] [Related]
12. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease. Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040 [TBL] [Abstract][Full Text] [Related]
14. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile. Silke B; Nelson GI; Ahuja RC; Taylor SH Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109 [TBL] [Abstract][Full Text] [Related]
15. How does posture influence the haemodynamic assessment of a cardiovascular drug? Experience with nicardipine. Silke B; Verma SP; Zezulka AV; Sharma S; Goldhammer E; Jackson N; Taylor SH J Cardiovasc Pharmacol; 1990 Jul; 16(1):87-92. PubMed ID: 1696670 [TBL] [Abstract][Full Text] [Related]
16. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease. Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772 [TBL] [Abstract][Full Text] [Related]
17. Single and divided doses of penbutolol. Müller FO; Hundt HK; Bromley PA; Torres J; Vanderbeke O Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):528-35. PubMed ID: 436357 [TBL] [Abstract][Full Text] [Related]
18. [Extent of beta-blocking action of S- and R-penbutolol during exercise testing (author's transl)]. Kober G; Schulz W; Hermann HJ; Kaltenbach M Z Kardiol; 1982 Apr; 71(4):289-94. PubMed ID: 6283753 [TBL] [Abstract][Full Text] [Related]
19. Haemodynamic dose-response actions of cicloprolol in left ventricular dysfunction due to ischaemic heart disease. Silke B; Verma SP; Sharma SK; Baig W; Jackson NC; Reynolds G; Frais MA; Taylor SH Int J Cardiol; 1987 Nov; 17(2):127-36. PubMed ID: 2890589 [TBL] [Abstract][Full Text] [Related]
20. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease. Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]